Fluidigm's Q4 Revenues Jump 26 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Tuesday that its fourth-quarter revenues increased 26 percent, driven by a 28 percent increase in product revenue.

The South San Francisco, Calif.-based firm reported total revenues of $13 million for the three-month period ended Dec. 31, compared to $10.4 million for the fourth quarter of 2010. Analysts had anticipated revenues of $12.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.